Literature DB >> 8115797

Total serum IgE and parasite-specific IgG and IgA antibodies in human strongyloidiasis.

C L Rossi1, E E Takahashi, C D Partel, L G Teodoro, L J da Silva.   

Abstract

Total serum IgE, and Strongyloides-specific IgG and IgA antibodies were studied in 27 patients with parasitologically proven strongyloidiasis. Clinical manifestations in this case series were investigated by a retrospective study of the patient's records. Total serum IgE levels were elevated (greater than 250 IU/ml) in 59% of the patients (mean concentration = 1364 IU/ml). Parasite-specific IgG and IgA antibodies were detected by ELISA in the serum of 23 (85.2%) and 21 (77.8%) patients, respectively. Elevated serum IgE and clinical manifestations were not useful indexes of the presence of strongyloidiasis. On the other hand, our results support the view that serologic tests, particularly ELISA for detecting Strongyloides-specific IgG antibodies, can be usefully exploited for diagnostic purposes in strongyloidiasis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8115797     DOI: 10.1590/s0036-46651993000400010

Source DB:  PubMed          Journal:  Rev Inst Med Trop Sao Paulo        ISSN: 0036-4665            Impact factor:   1.846


  8 in total

Review 1.  Screening, prevention, and treatment for hyperinfection syndrome and disseminated infections caused by Strongyloides stercoralis.

Authors:  Rojelio Mejia; Thomas B Nutman
Journal:  Curr Opin Infect Dis       Date:  2012-08       Impact factor: 4.915

2.  Assessment of the diagnostic value of specific anti-Toxocara IgA in Slovakian patients suspected to have toxocarosis.

Authors:  Vojtech Boldiš; František Ondriska; Simona Lipková
Journal:  Folia Microbiol (Praha)       Date:  2017-12-06       Impact factor: 2.099

Review 3.  Human infection with Strongyloides stercoralis and other related Strongyloides species.

Authors:  Thomas B Nutman
Journal:  Parasitology       Date:  2016-05-16       Impact factor: 3.234

4.  IgG1, IgG4, and IgE antibody responses in human strongyloidiasis by ELISA using Strongyloides ratti saline extract as heterologous antigen.

Authors:  Rosângela M Rodrigues; Maria C de Oliveira; Mônica C Sopelete; Deise A O Silva; Dulcinéa M B Campos; Ernesto A Taketomi; Julia M Costa-Cruz
Journal:  Parasitol Res       Date:  2007-07-04       Impact factor: 2.289

5.  Major histocompatibility complex (MHC) class II but not MHC class I molecules are required for efficient control of Strongyloides venezuelensis infection in mice.

Authors:  Rosângela M Rodrigues; Neide M Silva; Ana Lúcia R Gonçalves; Cristina R Cardoso; Ronaldo Alves; Flávia A Gonçalves; Marcelo E Beletti; Marlene T Ueta; João S Silva; Julia M Costa-Cruz
Journal:  Immunology       Date:  2008-12-16       Impact factor: 7.397

Review 6.  The laboratory diagnosis and follow up of strongyloidiasis: a systematic review.

Authors:  Ana Requena-Méndez; Peter Chiodini; Zeno Bisoffi; Dora Buonfrate; Eduardo Gotuzzo; José Muñoz
Journal:  PLoS Negl Trop Dis       Date:  2013-01-17

Review 7.  Strongyloides stercoralis Infection in Alcoholic Patients.

Authors:  Marcia C A Teixeira; Flavia T F Pacheco; Joelma N Souza; Mônica L S Silva; Elizabete J Inês; Neci M Soares
Journal:  Biomed Res Int       Date:  2016-12-26       Impact factor: 3.411

8.  Hepatobiliary strongyloidiasis presenting as an ampullary lesion on esophagogastroduodenoscopy/endoscopic ultrasound.

Authors:  Emmanuel Ofori; Daryl Ramai; Alisha Khan; Philip Xiao; Madhavi Reddy; Ghulamullah Shahzad
Journal:  Gastroenterol Rep (Oxf)       Date:  2018-02-26
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.